We are live on
!
Find out more
MIP
Mondrian Investment Partners Portfolio holdings
AUM
$6.48B
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
-10.75%
1 Year Est. Return
+18.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.72B
AUM Growth
-$1.18B
(-20%)
Cap. Flow
-$581M
Cap. Flow
% of AUM
-12.32%
Top 10 Holdings %
Top 10 Hldgs %
46.13%
Holding
142
New
45
Increased
33
Reduced
28
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$58M |
| 2 |
Johnson & Johnson
JNJ
|
+$58M |
| 3 |
Duke Energy
DUK
|
+$50.7M |
| 4 |
Texas Instruments
TXN
|
+$30.1M |
| 5 |
Procter & Gamble
PG
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$331M |
| 2 |
Avery Dennison
AVY
|
+$130M |
| 3 |
Baxter International
BAX
|
+$122M |
| 4 |
Ingredion
INGR
|
+$84.5M |
| 5 |
ENIA
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
|
+$39.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.48% |
| 2 | Financials | 14.72% |
| 3 | Healthcare | 13.54% |
| 4 | Utilities | 11.42% |
| 5 | Communication Services | 11.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cal-Maine
CALM
$3.99B
| $24K | ﹤0.01% |
+431
| New | +$23.1K |
|
127
iRadimed
IRMD
$1.18B
| $24K | ﹤0.01% |
+967
| New | +$23.1K |
|
|
DEST
128
DELISTED
Destination Maternity Corporation
DEST
| $24K | ﹤0.01% |
+2,573
| New | +$27.4K |
|
|
129
Baxter International
BAX
$14.2B
| $23K | ﹤0.01% |
700
-3,222,926
| -100% | -$122M |
|
130
WD-40
WDFC
$3.15B
| $23K | ﹤0.01% |
+258
| New | +$22.5K |
|
|
LBMH
131
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $23K | ﹤0.01% |
+9,912
| New | +$23.8K |
|
|
AAC
132
DELISTED
AAC Holdings
AAC
| $22K | ﹤0.01% |
+1,000
| New | +$29.1K |
|
133
Bio-Techne
TECH
$11.3B
| $21K | ﹤0.01% |
+912
| New | +$22.9K |
|
134
TC Energy
TRP
$65.9B
| $21K | ﹤0.01% |
503
+3
| +0.6% | +$108 |
|
|
ECOL
135
DELISTED
US Ecology, Inc.
ECOL
| $20K | ﹤0.01% |
+462
| New | +$22K |
|
136
ENI
E
$77.5B
| $19K | ﹤0.01% |
602
| – | – |
|
|
TGI
137
DELISTED
Triumph Group
TGI
| $19K | ﹤0.01% |
+455
| New | +$24.4K |
|
138
Woodward
WWD
$21.4B
| $19K | ﹤0.01% |
+472
| New | +$22.3K |
|
|
TBRG
139
DELISTED
TruBridge
TBRG
| $18K | ﹤0.01% |
+421
| New | +$20.3K |
|
|
ACC
140
DELISTED
American Campus Communities, Inc.
ACC
| $14K | ﹤0.01% |
+374
| New | +$13.6K |
|
141
TotalEnergies
TTE
$190B
| $10K | ﹤0.01% |
143,609,571
-133,852,816
| -48% | -$13.4K |
|
|
HCR
142
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $9K | ﹤0.01% |
+1,193
| New | +$19.8K |
|
Similar funds
HI
TCM
CG
BFS
BF
LAM
OCM
HFS
Mondrian Investment Partners's Q3 2015 Portfolio in Review
As of Q3 2015, Mondrian Investment Partners held 142 positions worth $4.72B, down 20% from $5.9B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Mondrian Investment Partners withdrew a net $581M in Q3 2015, reducing 28 holdings. Its largest reduction was Teva Pharmaceuticals, cutting an estimated $331M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Mondrian Investment Partners opened a new position in BAXALTA INC COM STK (DE) worth $52.9M.
- Mondrian Investment Partners's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 1,680,166 shares worth $52.9M.
- Mondrian Investment Partners added most to Johnson & Johnson in Q3 2015, an estimated $58M increase.
- Mondrian Investment Partners's biggest Q3 2015 reduction was Teva Pharmaceuticals, cutting an estimated $331M.
- Mondrian Investment Partners's ten largest holdings make up 46% of its $4.72B portfolio in Q3 2015.
- Mondrian Investment Partners opened 45 new positions and closed 0 in Q3 2015.
- Mondrian Investment Partners's portfolio value fell 20% quarter-over-quarter to $4.72B.
Based on Mondrian Investment Partners's 13F filing for Q3 2015, filed 20 Oct 2015.